Who Owns Assembly Biosciences Stock?
NASDAQ: ASMBHealth CareBiotechnology: Pharmaceutical PreparationsUSD
At close: Nov 20, 4:00 PM ET · Delayed 15 min
Ownership breakdown
- Held by institutions
- 76.83%
- Institutions (% of float)
- 106.70%
- Held by insiders
- 27.99%
- Institutional holders
- 149
- Institutions 72.0%
- Insiders 28.0%
- Public and other 0.0%
Who owns Assembly Biosciences stock?
Institutional investors own about 76.8% of Assembly Biosciences's shares, spread across 149 institutions that file 13F reports. That level of institutional ownership is high, typical of large, widely followed companies. Insiders, including executives, directors and large founding shareholders, hold 27.99% of ASMB.
The largest institutional holders are Gilead Sciences Inc (24.44%), Farallon Capital Management LLC (7.88%) and Paradigm Biocapital Advisors LP (7.63%). Together, the top 10 institutions control 72.6% of shares outstanding. In their latest filings, 8 of the top 10 institutions increased their ASMB positions and 0 reduced them.
Summary generated from market data by MetaCap's automated system. Methodology
Top institutional holders of ASMB
| Institution | Shares | % Held | Change |
|---|---|---|---|
| Gilead Sciences Inc | 4.98M | 24.44% | 0.0% |
| Farallon Capital Management LLC | 1.60M | 7.88% | +30.7% |
| Paradigm Biocapital Advisors LP | 1.55M | 7.63% | +133.6% |
| Blackrock Inc. | 1.49M | 7.31% | +94.0% |
| Commodore Capital Lp | 1.42M | 6.95% | +41.5% |
| RA Capital Management, L.P. | 1.02M | 5.01% | 0.0% |
| Jupiter Topco LLC | 849.31K | 4.17% | +100.0% |
| Parkman Healthcare Partners LLC | 721.18K | 3.54% | +75.4% |
| Vanguard Capital Management LLC | 602.93K | 2.96% | +7.9% |
| State Street Corporation | 559.59K | 2.75% | +225.5% |
% held is the share of total shares outstanding. Change is the percentage change in the position since the holder's previous 13F filing.
Top mutual fund and ETF holders of ASMB
| Fund | Shares | % Held |
|---|---|---|
| VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund | 413.28K | 2.03% |
| iShares Trust-iShares Russell 2000 ETF | 340.73K | 1.67% |
| SPDR SERIES TRUST-State Street SPDR S&P Biotech ETF | 301.74K | 1.48% |
| VANGUARD INDEX FUNDS-Vanguard Extended Market Index Fund | 133.29K | 0.65% |
| abrdn Healthcare Investors | 129.71K | 0.64% |
| iShares Trust-iShares Russell 2000 Value ETF | 123.43K | 0.61% |
| Fidelity Salem Street Trust-Fidelity Small Cap Index Fund | 107.39K | 0.53% |
| abrdn Life Sciences Investors | 77.34K | 0.38% |
| Fidelity Concord Street Trust-Fidelity Extended Market Index Fund | 67.61K | 0.33% |
| VANGUARD SCOTTSDALE FUNDS-Vanguard Russell 2000 Index Fund | 56.41K | 0.28% |
Frequently asked questions
Who is the largest shareholder of Assembly Biosciences?
Gilead Sciences Inc is the largest institutional shareholder of ASMB, owning 24.44% of shares outstanding (4.98M shares) as of its latest 13F filing.
What percentage of Assembly Biosciences is owned by institutions?
Institutions own about 76.8% of ASMB shares and 106.7% of the public float.
How much of Assembly Biosciences do insiders own?
Insiders, such as officers and directors, own about 27.99% of ASMB shares outstanding.
Where does institutional ownership data come from?
Investment managers with more than $100 million in US equities must file Form 13F with the SEC within 45 days of each quarter-end. Holdings are therefore up to about 4.5 months old when published.